Pricing Sign in

Role
Country
Date of registration
Address

Made In Tracker

Made In Tracker EasyUDI

Legal

Privacy Policy Legal Notice

About

About FAQ Partners Contact

Our data is continuously updated and sourced from EUDAMED, the European database for medical devices and in vitro diagnostics.

Subscribe to our monthly newsletter:

By subscribing, you accept the General Personal Data Protection Policy.

Organization name
UDI-DI code
Reference / catalog number

D-Mannose effervescent GR — Class IIa MDD by PK Benelux BV

MD Atlas
PK Benelux BV

EUDAMED last updated this device on May 5, 2026

D-Mannose effervescent GR

B-071466NV

On the marketClass IIa

Applicable legislation: MDD [Directive 93/42/EEC on medical devices]
Organization name: PK Benelux BV
UDI-DI code: D-071466NV
Reference / catalog number: 071466

Sign in to open the EUDAMED record

The link to the official EUDAMED page is reserved for signed-in users. Create a free account to continue.

Email

Password

No account yet?

View device family (Basic UDI)

Manufacturer information

Organization name: PK Benelux BV
SRN: NL-MF-000006672
Manufacturer status: Active

Critical warnings

1 warning recorded — scroll inside the panel to see all entries.

CW999
Warning: • Do not use when allergic to any of the ingredients; • Adverse effects may occur in overdose, such as flatulence, stomach ache or diarrhoea; • Keep out of reach of young children; • If you experience allergic reactions, stop using D-mannose Urinary tract; • The product can cause beeturia (red/pink discoloration of the urine) due to excipient beetroot red extract. Consult your doctor if: • You discover traces of blood in the urine; • Symptoms worsen or persist after 7 days; • You have an existing medical condition or are taking other medication; • You have symptoms of bladder or upper urinary tract infection such as a fever of 38 °C (100.4F) or higher, noncontrollable shivering, nausea (feeling sick), vomiting or diarrhoea. You may suffer from an upper urinary tract infection, which needs additional treatment; • You have a history of kidney stones. Use during pregnancy and/or breastfeeding: No data are available concerning the use of D-mannose Urinary tract during pregnancy or breastfeeding. Therefore you cannot use this product during pregnancy or breastfeeding. Side effect(s): Lucovital® D-Mannose Urinary tract has few side effects and is generally well tolerated. Gastro intestinal symptoms as diarrhea, stomach aches, flatulence are possible side effects.

EasyUDICompliance engine

Sponsored

Your devices, UDI-compliant — without drowning in regulation

EUDAMED-ready· UDI-enriched

Basic UDIUDI-DIUDI-PIAttributeDocument

Print-ready label

From your product file — no manual entry

Exclusive to MD Atlas usersClaim my −20% discount

by Made In Tracker

Market distribution

Primary placement in EL; available across 1 country total.

Country	On market since	Until
ELPrimary placement	Oct 31, 2018	Still on market

Device identification

Trade name: D-Mannose effervescent GR
UDI-DI code: D-071466NV
Basic UDI-DI: B-071466NV
Reference / catalog number: 071466
Issuing entity: EUDAMED

Classification

Risk category: Class IIa
Applicable legislation: MDD [Directive 93/42/EEC on medical devices]
Status: On the market

Device details

Quantity: 1
Additional product description: To prevent and support the treatment of urinary tract infections
Additional information URL: No additional information URL provided by the manufacturer.
Clinical sizes: No clinical sizes registered for this device.

UDI-PI traceability

Batch number
Expiration date
Manufacturing date
Serial number
Software identification

UDI-DI DataMatrix

D-071466NV

DataMatrix generation currently supports GS1-issued UDIs. HIBCC / ICCBBA support is coming.

EMDN nomenclature code(s)

European Medical Device Nomenclature — the EU product classification assigned to this device.

G0499ORALLY ADMINISTERED GASTROINTESTINAL DEVICES - OTHER

Compliance flags

Safety

Sterile

Single use

Contains latex

Reprocessed single-use

Direct marking

Substances

CMR substance

Endocrine disruptor

Regulatory

Annex XVI applicable

Sterilization

Lifecycle

New device

Become a partner of MD Atlas

Related devices

RedCare Anti Fusspilz-gelB-17983001CUOn the market ABC Bacterial Vaginosis 5x7 mlB-954854SWOn the market Acetocaustin 2 mlB-073415NSOn the market ActiveMed D-Mannose 28 sB-073156NROn the market Activemed Flacher BauchB-073224NHOn the market

Certificates

No certificates registered for this manufacturer.

No certificate references this Basic UDI-DI, because: • It does not require a certificate, or • It only requires a certificate without a Basic UDI-DI reference (e.g. a QMS certificate), or • The required certificate(s) referencing this Basic UDI-DI have not been registered yet.